H.R. 6240 · 115th Congress
Drug Discount Accountability Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
CollinsSponsor1 cosponsor · 1 R
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill requires the Health Resources and Services Administration to collect a user fee from certain entities participating in the 340B drug pricing program, including critical access hospitals, for activities relating to program oversight and improvement.
What it does: CRS summary · Introduced in House · Jun 27, 2018
Drug Discount Accountability Act
This bill requires the Health Resources and Services Administration to collect a user fee from certain entities participating in the 340B drug pricing program, including critical access hospitals, for activities relating to program oversight and improvement.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Drug Discount Accountability Act
Latest action (Jun 27, 2018): Referred to the House Committee on Energy and Commerce.
Policy area: Health · Origin: House · Introduced: Jun 27, 2018
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.